BR112023018654A2 - Compostos antibacterianos - Google Patents
Compostos antibacterianosInfo
- Publication number
- BR112023018654A2 BR112023018654A2 BR112023018654A BR112023018654A BR112023018654A2 BR 112023018654 A2 BR112023018654 A2 BR 112023018654A2 BR 112023018654 A BR112023018654 A BR 112023018654A BR 112023018654 A BR112023018654 A BR 112023018654A BR 112023018654 A2 BR112023018654 A2 BR 112023018654A2
- Authority
- BR
- Brazil
- Prior art keywords
- antibacterial compounds
- compounds
- antibacterial
- tuberculosis
- medicines
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
compostos antibacterianos. a presente invenção refere-se aos compostos (i) em que os números inteiros são conforme definidos na descrição, e em que os compostos podem ser úteis como medicamentos, por exemplo, para uso no tratamento de tuberculose.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21163042 | 2021-03-17 | ||
| PCT/EP2022/056774 WO2022194906A1 (en) | 2021-03-17 | 2022-03-16 | Antibacterial compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023018654A2 true BR112023018654A2 (pt) | 2023-10-03 |
Family
ID=74947094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023018654A BR112023018654A2 (pt) | 2021-03-17 | 2022-03-16 | Compostos antibacterianos |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4308579A1 (pt) |
| JP (1) | JP2024509998A (pt) |
| KR (1) | KR20230157445A (pt) |
| CN (1) | CN117440958A (pt) |
| AU (1) | AU2022236404A1 (pt) |
| BR (1) | BR112023018654A2 (pt) |
| CA (1) | CA3212074A1 (pt) |
| WO (1) | WO2022194906A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR127483A1 (es) * | 2021-10-28 | 2024-01-31 | Janssen Sciences Ireland Unlimited Co | Compuestos antibacterianos |
| WO2024089170A1 (en) * | 2022-10-27 | 2024-05-02 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1527050B1 (en) | 2002-07-25 | 2010-04-07 | Janssen Pharmaceutica N.V. | Quinoline derivatives and their use as mycobacterial inhibitors |
| PL2547678T3 (pl) | 2010-03-18 | 2016-10-31 | Związki przeciwzapalne | |
| ES2761332T3 (es) | 2011-09-01 | 2020-05-19 | Novartis Ag | Compuestos y composiciones como inhibidores de la cinasa c-kit |
| US9199981B2 (en) | 2011-09-01 | 2015-12-01 | Novartis Ag | Compounds and compositions as C-kit kinase inhibitors |
| KR102178590B1 (ko) | 2012-07-18 | 2020-11-13 | 유니버시티 오브 노트르 담 듀락 | 5,5-헤테로방향족 항-감염 화합물 |
| CN109575018A (zh) | 2013-08-02 | 2019-04-05 | 韩国巴斯德研究所 | 一种抗感染化合物 |
| BR112017028318B1 (pt) | 2015-07-02 | 2024-02-20 | Janssen Sciences Ireland Uc | Composto antibacteriano, seu uso, processo para sua preparação,produto que o contém, composição farmacêutica e combinação |
| CA3026010A1 (en) | 2016-06-16 | 2017-12-21 | Janssen Sciences Ireland Unlimited Company | Heterocyclic compounds as antibacterials |
| BR112018075939A2 (pt) | 2016-06-16 | 2019-04-09 | Janssen Sciences Ireland Unlimited Company | compostos heterocíclicos como antibacterianos |
-
2022
- 2022-03-16 EP EP22715593.4A patent/EP4308579A1/en active Pending
- 2022-03-16 JP JP2023556984A patent/JP2024509998A/ja active Pending
- 2022-03-16 AU AU2022236404A patent/AU2022236404A1/en active Pending
- 2022-03-16 KR KR1020237035185A patent/KR20230157445A/ko unknown
- 2022-03-16 WO PCT/EP2022/056774 patent/WO2022194906A1/en active Application Filing
- 2022-03-16 CN CN202280035910.6A patent/CN117440958A/zh active Pending
- 2022-03-16 CA CA3212074A patent/CA3212074A1/en active Pending
- 2022-03-16 BR BR112023018654A patent/BR112023018654A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN117440958A (zh) | 2024-01-23 |
| EP4308579A1 (en) | 2024-01-24 |
| KR20230157445A (ko) | 2023-11-16 |
| WO2022194906A1 (en) | 2022-09-22 |
| AU2022236404A1 (en) | 2023-11-02 |
| CA3212074A1 (en) | 2022-09-22 |
| JP2024509998A (ja) | 2024-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017028318A2 (pt) | compostos antibacterianos | |
| BR112018076126A2 (pt) | compostos heterocíclicos como antibacterianos | |
| BR112018075939A2 (pt) | compostos heterocíclicos como antibacterianos | |
| BR112022003799A2 (pt) | Compostos antibacterianos | |
| BR112023018654A2 (pt) | Compostos antibacterianos | |
| BR112023018655A2 (pt) | Compostos antibacterianos | |
| BR112017027414A2 (pt) | Derivados hidroxiéster, processo para prepará- los e composições farmacêuticas os contendo | |
| BR112018070161A2 (pt) | moduladores de receptores de estrogênio | |
| BR112016017261A8 (pt) | composto, composição farmacêutica, uso de um composto e processo para a fabricação de um composto | |
| BR112022023271A2 (pt) | Compostos | |
| BR112018014536A2 (pt) | derivados de amônio, um processo para sua preparação e composições farmacêuticas contendo os mesmos | |
| UY38428A (es) | Nuevos compuestos antihelmínticos | |
| BR112012010270A2 (pt) | mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco | |
| BR112017027831A2 (pt) | derivados de hidroxiácido, um processo para sua preparação e composições farmacêuticas contendo-os | |
| BR112019024830A2 (pt) | inibidores de bcl6 derivados de benzimidazolona | |
| BR112022021881A2 (pt) | Novos compostos de triazinoindol | |
| BR112013008667A2 (pt) | compostos substituídos de benzamida | |
| BR112022004699A2 (pt) | Vs-6063 em combinação com ch5126766 para o tratamento de câncer | |
| BR112022020798A2 (pt) | Compostos tricíclicos como inibidores de nlrp3 | |
| BR112022020776A2 (pt) | Pirrolo[1,2-d][1,2,4]triazina-2-il-acetamidas como inibidores da via do inflamassoma de nlrp3 | |
| BR112019005886A2 (pt) | tratamento com água de material lipídico | |
| BR112017019750A2 (pt) | processo para preparação de uma forma cristalina de menaquinol, forma cristalina de menaquinol, processo para preparação de uma forma sólida do menaquinol, composição farmacêutica ou nutracêutica e uso da forma cristalina de menaquinol | |
| BR112022024045A2 (pt) | Moduladores il-17a | |
| BR112022005068A2 (pt) | Compostos antibacterianos de 4-quinolinona | |
| BR112022005449A2 (pt) | Compostos antibacterianos |